A double-blind, placebo-controlled, parallel, randomized study to evaluate the efficacy and safety of 3 oral dose levels of TMI-005 [apratastat] in subjects with active rheumatoid arthritis on a background of methotrexate

Trial Profile

A double-blind, placebo-controlled, parallel, randomized study to evaluate the efficacy and safety of 3 oral dose levels of TMI-005 [apratastat] in subjects with active rheumatoid arthritis on a background of methotrexate

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Apratastat (Primary) ; Methotrexate
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top